Loss of vascular pericytes has long been associated with the onset of diabetic retinopathy; however, mechanisms contributing to pericyte dropout are not understood. Notch3 has been implicated in pericyte stability and survival, and linked to vascular integrity. Notch3 mutant mice exhibit progressive loss of retinal pericytes. Given that diabetic retinopathy is associated with pericyte loss, we sought to determine whether perturbation of Notch3 signaling contributes to diabetes-induced pericyte dropout and capillary degeneration. We utilized a pericyte-expressed LacZ transgene (XlacZ4) to examine pericyte loss in retinas of a type I diabetic mouse model (Ins2Akita) and Notch3-deficient mice. Notch3 null animals showed a dramatic loss of the LacZ marker by 8 weeks of age, while Ins2Akita diabetic and Notch3 heterozygous mice exhibited a much slower and subtler loss of LacZ. Although combined Notch3 heterozygosity in Ins2Akita diabetic animals did not show further deficits, the trypsin digest method revealed that Notch3 haploinsufficiency increased the formation of acellular capillaries in diabetic mice. Our data further indicate that Notch signaling is blunted in diabetic retinas and in cells exposed to hyperglycemia. These results are the first to demonstrate an association between Notch3 signaling, pericyte loss, and diabetic retinopathy.
to increased vascular permeability, retinal ischemia, and microaneurysms [1, 5] . One of the earliest events in diabetic retinopathy is pericyte loss or dropout, which contributes to vascular instability and disease progression [5] [6] [7] . Understanding what promotes this critical step and identifying ways to prevent pericyte dropout is an important component in controlling disease progression. However, the mechanistic link between diabetes, hyperglycemia and pericyte loss is not well defined.
Retinal pericytes are vascular support cells that surround the endothelial cell-lined vessels and provide stability and tone to promote proper blood flow [6, 8, 9] . They also serve an important role in maintenance of the blood-retina barrier and are a critical part of the neurovascular unit by regulating permeability, clearance of toxic metabolites, and neuroinflammation [10, 11] . While pericyte loss or disruption has been linked to an array of diseases, including fibrosis and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [9, 12] , it is unequivocally tied to diabetic retinopathy and is one of the earliest morphological indicators of the disease [5] [6] [7] . Some evidence has linked hyperglycemia to the cause of pericyte loss, with some indication that it is a result of increased reactive oxygen species [1, 8, 13] . Despite these important studies, the direct mechanisms contributing to pericyte dropout remain elusive.
Genetic and molecular approaches have identified certain pathways that contribute to pericyte homeostasis and function. Ligand/receptor combinations from the platelet-derived growth factor-β, transforming growth factor-β, and angiopoietin-1 signaling families are known to contribute to pericyte recruitment, migration, and stability [9, 11, 13] . Additionally, the Notch signaling pathway has also been linked to pericyte differentiation and survival [14] [15] [16] [17] . The Notch3 receptor is enriched in vascular smooth muscle cells and pericytes, and is the causative gene of CADASIL, which is an autosomal dominant stroke disorder resulting in vascular dementia [18, 19] . Genetic deletion studies have revealed its importance in smooth muscle maturation and homeostasis and bloodbrain barrier function [16] [17] [18] 20] . In the retina, Notch3 is expressed in pericytes [21] [22] [23] , and genetic deficiency results in progressive loss of retinal pericytes, which is linked to its role in cell survival [23, 24] .
In this study we examined the relationship of pericyte loss in Notch3 deficiency and diabetes. Using a pericyteexpressed LacZ transgene (XlacZ4) [25] , we show that Notch3 null mice have substantially reduced expression of the transgene at 8 weeks of age, while heterozygous mice exhibit a much slower and progressive loss of the LacZ expression. Evaluation of LacZ expression in the type I diabetic Ins2 Akita mice [26] [27] [28] showed reduced expression that parallels that of Notch3 haploinsufficiency; however, examination of Notch3 haploinsufficiency in Ins2 Akita diabetic mice revealed no association. Utilization of trypsin digest to evaluate acellular capillaries demonstrated that Notch3 heterozygosity did not significantly increase acellular capillaries, while the Ins2 Akita diabetic mice had significant increases in acellular capillaries at 24 weeks of age. Importantly, Notch3 haploinsufficiency further increased acellular capillaries in the Ins2 Akita diabetic mice. Evaluation of Notch signaling components in diabetic mice showed alterations in select transcripts, and in vitro experiments to evaluate Notch activity in cocultured vascular cells indicated that Notch signaling is blunted by hyperglycemia. 
Results

Notch3 Deficiency Causes a Dose-Dependent Decrease in XlacZ4 Transgene Expression
Previously, others and we demonstrated that Notch3 mutant mice have progressive loss of retinal pericytes and smooth muscle cells [16, 17, 23, 24] . As a simple method to track pericyte loss, we utilized an XLacZ4 transgenic mouse line (B6.FVB-Tg(Fabp4-lacZ)4Mosh/J, Stock No.: 018625) [25] , which expresses the LacZ reporter gene under the control of a smooth muscle-and pericyte-specific promoter, to demarcate retinal pericytes (Fig. 1) [29, 30] . The XLacZ4 transgenic mice were crossed with mice harboring the Notch3 null mutation (Notch3 -/-), and LacZ expression was evaluated in retinas of mice at 8 weeks of age. LacZ staining in flat-mounted retinas revealed that in the absence of functional Notch3 there was a dramatic loss of the XlacZ4 transgene expression, compared to the wild-type control (Fig. 2) (WT 1.02 ± 0.152, N3/N3 0.09 ± 0.052). Notch3 +/-retinas showed a less severe loss of LacZ transgene expression (N3/+ 0.73 ± 0.136), but staining was still significantly reduced and distinguishable from wild-type and Notch3 -/-mice (Fig. 2) . Thus, the XLacZ4 transgene exhibited Notch3-reliant expression that was dose-dependent and consistent with the loss of pericytes. weeks of age and begin to develop retinal complications at 12 weeks [26] [27] [28] . Using the XlacZ4 transgene we evaluated pericytes in Ins2 Akita diabetic mice at 12, 16, and 24 weeks of age. Quantification of LacZ staining revealed no significant difference in pericyte numbers between wildtype and diabetic mice at 12 and 16 weeks (Fig. 3a) ; however, there was a significant decrease in LacZ staining at 24 weeks (Fig. 3a, b ) (WT24 1.0 ± 0.131, AK24 0.78 ± 0.142). At 24 weeks the vessels of the diabetic mice appeared thinner, with less LacZ-positive pericytes at the periphery of the blood vessels.
Analysis of Pericytes and Acellular Capillaries in
Given that the XlacZ4 transgene could detect pericyte loss in both Notch3-deficient and Ins2 Akita diabetic mice, we next tested whether the combination of Notch3 deficiency and diabetes would show an exacerbated loss of pericytes at 24 weeks. Because Notch3 homozygous null mice have severe pericyte loss prior to the onset of a diabetic phenotype in Ins2 Akita animals, we utilized Notch3 heterozygous mice to cross with Ins2 Akita mice for these analyses. Comparing blood glucose and body weights of control and Ins2 Akita mice showed the expected increase and decrease in these parameters. Importantly, the combined Notch3 +/-;Ins2 Akita mice were not statistically different from Ins2 Akita animals ( Fig. 4a, b) . Evaluation of the pericyte population with the XlacZ4 transgene revealed that compared to Notch3 +/-and Ins2 Akita , the combined Notch3 +/-;Ins2 Akita mice were not significantly different. Compared to the wild-type control, all 3 genotypes (Notch3 +/-, Ins2 Akita , and Notch3 +/-;Ins2 Akita ) were different from control, but not from one another (Fig. 4c ) (WT 1.00 ± 0.159, N3/+ 0.59 ± 0.124, AK 0.68 ± 0.147, AK;N3 0.63 ± 0.212). The reduced XlacZ4 transgene expression may reflect pericyte injury rather than pericyte loss based on evidence that this marker is downregulated in response to mechanical vascular injury [11, 25] .
In diabetic retinopathy, pericyte loss is accompanied by acellular capillary formation [26, 33] . Acellular capillaries are basement membrane tubes without cell nuclei that have at least one fourth of the normal capillary diameter [26, 33] . To further examine the consequence of Notch3 deficiency in diabetic mice, we utilized trypsin digestion to quantify acellular capillaries of the retina. Interestingly, at 24 weeks Notch3 +/-retinas were indistinguishable from wild-type controls (Fig. 5a, b) . Conversely, Ins2 Akita mice exhibited an increase in acellular capillaries, which was exacerbated in the Notch3 +/-; Ins2 Akita mice (Fig. 5a, b) 
Notch Signaling Is Perturbed by Hyperglycemia
To determine whether diabetic conditions affect Notch signaling, we evaluated expression by quantitative (q) PCR in whole retinas of wild-type and Ins2 Akita mice at 24 weeks of age. Notch3 and jagged1 (Jag1) have been characterized as the major receptor/ligand pair that facilitates endothelial cell-pericyte interactions [34] [35] [36] . Expression analysis of Notch3 showed no significant difference between control and diabetic mice, while the Jag1 ligand exhibited increased expression in retinas of Ins2 Akita mice (Fig. 6a) . Downstream targets, Hes1 and smooth muscle α-actin (Acta2), showed a significant decrease in the diabetic retinas, whereas HeyL was not changed (Fig. 6b) . These data indicate that Notch signaling is altered in diabetes, and that certain Notch components may be selectively targeted. Previously our lab demonstrated that endothelial cells via the Jag1 ligand increase Notch3 expres- sion and activate Notch signaling in cocultured smooth muscle cells and pericytes [36] . Using a Notch-sensitive luciferase reporter transfected into human retinal pericytes, we can measure endothelial cell-dependent Notch activation in a cell-specific manner (Fig. 7a) . To evaluate whether Notch activation is influenced by hyperglycemia, we measured Notch signaling in transfected retinal pericytes cultured alone or with human retinal endothelial cells in normal and high glucose conditions. The data show that Notch activation by cocultured endothelial cells is blunted by hyperglycemia (Fig. 7b) (cocultured low glucose 5.6 ± 1.81, cocultured high glucose 4.3 ± 2.13). We also examined the expression of Notch3 or Jag1 in hyperglycemic conditions but did not observe significant differences (not shown), suggesting that expression does not reflect Notch activity. These data, together with the decrease in Notch target genes in diabetic mice suggests that Notch signaling is perturbed by diabetes.
Materials and Methods
Mice
All strains were obtained from Jackson Laboratory and maintained in C57BL/6 background: Notch3 (B6; 129S1-Notch3 tm1Grid /J, Stock No.: 010547) [37] , Akita (C57BL/6-Ins2 Akita /J, stock No.: 003548) [26] , XLacZ4 (B6.FVB-Tg(Fabp4-lacZ)4Mosh/J, Stock No.: 018625) [25] . Genotyping of mice was carried out by PCR following Jackson Laboratory protocols. All mouse studies were per- formed in accordance with protocols approved by the Institutional Animal Care and Use Committee at the Research Institute at Nationwide Children's Hospital. For experiments with diabetic mice, only heterozygous Ins2 Akita male mice were used, with wildtype male mice used as controls. Age-matched mice were grouped and evaluated based on relevant genotypes. Blood glucose was measured following an 8-hour fasting period using tail vein blood with AlphaTrak 2 Blood Glucose Strips (Abbott) and Glucometer. Experimental groups of mice were weighed every week after weaning on a consistent schedule.
LacZ Staining on Whole-Mount Retinas
For staining of β-galactosidase activity, eyes were isolated from mice at indicated time points and fixed in 2% formaldehyde (Fisher) plus 0.2% glutaraldehyde (Sigma) for 30 min. The cornea and lens were removed, and retinas were placed in staining solution overnight at room temperature. The staining solution to detect LacZ activity consisted of 5 mM K 4 Fe(CN) 6 , 5 mM K 3 Fe(CN) 6 , 2 mM MgCl 2 , 0.02% NP-40, and 0.1% X-gal in PBS buffer (all chemicals from Sigma). After staining, retinas were postfixed with 4% formaldehyde overnight. The remaining sclera and vitreous were removed to isolate retinas, and radial incisions were made at equal intervals along the retinal edge. Retinas were flat mounted with Vectashield (Vector Laboratories). LacZ images were captured using a Zeiss AXIO microscope with ZEN pro software and equivalent settings. LacZ was quantified with NIH ImageJ software using a fixed threshold to measure colored pixels. Relative LacZ expression is graphed with a wild-type control reference sample set to 1.
Trypsin Digestion of Mouse Retina and Staining
Eyes were fixed in 2% paraformaldehyde at room temperature overnight. On the second day, retinas were isolated and digested in 3% Difco Trypsin 250 (BD Biosciences) for 6 h at 37 ° C. After careful removal of internal limiting membranes, the neuroretinal tissue was gently brushed away. Next, retinas were allowed to stand in 0.5% Triton X-100 solution until the complete removal of neurons. Preparations of retinal vascular networks were set onto glass microscope slides in distilled water, air-dried and stained with periodic acid-Schiff and hematoxylin for histologic evaluation. Acellular capillaries were counted at 200× magnification in 8 fields per retina in multiple midretinal areas and averaged.
RNA Isolation and qPCR
Total RNA was extracted from mouse retinas using TissueLyser (Qiagen) homogenation in TRIzol (Invitrogen) according to the manufacturer's instructions. RNA was reverse transcribed with M-MLV reverse transcriptase (Promega) to generate cDNA. qPCR was performed using a StepOne PCR system (Applied Biosystems) with Power SYBR Green. The relative difference in various transcripts was calculated by the ΔΔC T method using ribosomal protein L13a (Rpl13A) as the internal control/reference gene. Primer sequences for mouse transcripts were as follows: Notch3 forward 5′-TTG TCT GGA TGG AAG CCC ATG T-3′; Notch3 reverse 5′-ACT GAA CTC TGG CAA ACG CCT-3′; Jag1 forward 5′-GGC TTC TCA CTC AGG CAT GAT A-3′; Jag1 reverse 5′-GTG GGC AAT CCC TGT GTT TT-3′; Hes1 forward 5′-CCC CAG CCA GTG TCA ACA C-3′; Hes1 reverse 5′-TGT GCT CAG AGG CCG TCT T-3′; HeyL forward 5′-CGC AGA GGG ATC ATA GAG AAA CG-3′; HeyL reverse 5′-GCC AGG GCT CGG GCA TCA AAG AA-3′; Acta2 forward 5′-TCC TGA CGC TGA AGT ATC CGA TA-3′; Acta2 reverse 5′-GGT GCC AGA TCT TTT CCA TGT C-3′; Rpl13A forward 5′-TCC CTG CTG CTC TCA AGG-3′; Rpl13A reverse 5′-GCC CCA GGT AAG CAA ACT T-3′.
Cell Culture
Primary human retinal pericytes (Cell-Systems) were grown in Dulbecco's modified Eagle's medium (Mediatech Inc.) supplemented with 5% fetal bovine serum (Hyclone), 2 mM glutamine, 1 mM sodium pyruvate, and 100 U/mL penicillin-streptomycin. Primary human retinal microvascular endothelial cells (Cell-Systems) were maintained in EBM-2 media (Lonza) supplemented with the bullet kit as recommended. Cells between passages 6 and 9 were used for all experiments. All cultures were maintained in humidified 5% CO 2 at 37 ° C.
Plasmid Transfection and Reporter Assays
A Notch sensor containing 5 × CBF1 binding sites upstream of the luciferase reporter was generated as described [36, 38] . For normalizing transfection efficiency, CMV promoter-driven secreted embryonic alkaline phosphatase (SEAP) (Addgene: #24595) reporter plasmid was cotransfected with the luciferase reporter [38] . To measure Notch transcriptional activity, retinal pericytes at 80% confluency were transfected with the reporter plasmids using Lipofectamine 3000 (Invitrogen). Following transfection, pericytes were cultured in media with high (25 mM) or low (5 mM) glucose, and retinal endothelial cells were added to select wells for coculture and activation of Notch signaling for 48 h. All coculture and control alone experiments were performed in media consisting of EBM-2 supplemented with the bullet kit and indicated glucose concentration. Luciferase activity was measured with the BrightGlo assay kit (Promega), and SEAP activity was measured with a Phospha-Light System (Applied Biosystems). Activity was quantified using a Molecular Devices SpectroMax luminometer [36, 38] . All experiments were performed in duplicate and repeated a minimum of 3 times.
Statistical Analysis
Data analyses were performed using GraphPad Prism. Comparisons between data sets were made using Student's t test or ANOVA, with differences considered significant if p < 0.05. Data are presented as means ± SD, unless otherwise indicated. Data shown are representative of at least 3 independent experiments, and/or the n value is indicated with data.
Discussion
Diabetic retinopathy is one microvascular complication associated with diabetes and a leading cause of blindness [1, 2] . One of the first indicators of diabetic retinopathy is a loss of pericytes surrounding the blood vessels. This leads to progression of the disease that includes increased vascular permeability, capillary degeneration, retinal microaneurysms and hemorrhage, and devolves into the proliferative stage, which ultimately leads to blindness [5] [6] [7] . While pericyte dropout is a defining feature of the early stages of the disease, the mechanisms that DOI: 10.1159/000493151 contribute to this important step are not known. Data from several labs have demonstrated that Notch signaling, in particular the Notch3 receptor, is essential for pericyte stability and survival, and therefore seemed a likely candidate as a contributor to diabetes-induced pericyte loss [14] [15] [16] [17] 23] . To examine this possible link, we examined pericyte loss in Notch3 mutant and diabetic mouse models using a pericyte-expressed LacZ reporter transgene. The data indicate that loss of the pericyte marker is profoundly affected by Notch3 deficiency. Previous studies with the XlacZ4 transgene revealed this marker is downregulated in response to vascular crush injury [11, 25] , and thus loss of Notch3 may be a perceived insult that promotes this event. Others and we have previously shown loss of Notch3 promotes apoptosis in the retina [16, 23, 39] . Notch3 haploinsufficiency and the Ins2 Akita diabetic mice exhibited similar temporal profiles of LacZpositive pericytes and did not show an additive or cooperative effect in combination, which is surprising given they both contribute to pericyte loss. These data suggest that the XlacZ4 transgene may not be a suitable tool for monitoring pericyte loss due to its downregulation in response to various stressors.
Pericyte loss is a hallmark of diabetic retinopathy and is suggested to contribute to capillary degeneration in disease [13] . Using trypsin digest to assess acellular capillaries revealed that Notch3 heterozygosity showed no significant difference in capillary degeneration at 24 weeks, while Ins2 Akita diabetic mice exhibited a significant increase in acellular capillaries compared to wild-type control. Interestingly, combined Notch3 haploinsufficiency and Ins2 Akita diabetes resulted in an additional increase in capillary degeneration, suggesting that perturbation of Notch3 likely diminishes the vascular protecting function of pericytes and therefore causes retinal capillaries to be more sensitive to diabetic conditions. Notch3 haploinsufficiency in diabetic mice does not affect pericyte loss but does affect the number of acellular capillaries, which is difficult to interpret. Possibly diabetes and haploinsufficiency both impair Notch signaling in pericytes, preventing an additive effect. However, this does not apply to the capillaries themselves, and there could be pericyte-independent functions of Notch3 that are responsible for capillary loss.
In examining Notch signaling components in retinas of diabetic mice, we evaluated Notch3 receptor and Jag1 ligand, which are known to play prominent roles in endothelial cell to mural cell (smooth muscle and pericytes) signaling [35, 36, 40] . At the transcript level, we observed no significant difference in Notch3 expression between normal and diabetic retinal tissue, while Jag1 showed an increase in diabetic mice compared to controls (WT 0.99 ± 0.291, AK 1.378 ± 0.769). The increase in Jag1 is consistent with previous publications [41, 42] , and indicates that diabetes may influence Notch signaling through altering the receptor/ligand ratio. Indeed, examination of known downstream targets of Notch signaling [34] showed varied differences, with Hes1 and smooth muscle α-actin (Acta2) having decreased expression in diabetic mice indicative of reduced Notch activity (Hes1 WT 0.69 ± 0.291, AK 0.32 ± 0.335, Acta2 WT 0.86 ± 0.798, AK 0.51 ± 0.666); however, HeyL remained unchanged. This implies that diabetic effects on Notch signaling are not straightforward and may be indirect. Given that the retina is composed of an array of different cell types, it is difficult to assess whether these changes, or lack thereof, can be directly linked to Notch signaling in vascular cells. To address the direct effect of hyperglycemia on vascular cells, we utilized a previously published coculture model [36, 43] to evaluate Notch activity between endothelial cells and pericytes. Utilization of a Notch sensor luciferase construct transfected into retinal pericytes followed by coculture with retinal endothelial cells, we demonstrate robust endothelial cell-dependent Notch activation. Comparing Notch activity in normal glucose versus high glucose culture conditions, we observed hyperglycemia blunted the Notch signaling response. Thus, these data indicate that glucose affects Notch signaling, and this ability to perturb Notch signaling between endothelial cells and pericytes may be a contributing factor to pericyte loss in diabetes. Notch signaling has been directly linked to pericyte survival and support of the microcirculation [14] [15] [16] [17] 23] . These data are the first to demonstrate a link between Notch3 signaling and pericyte loss associated with diabetes. Our results suggest that disruption of endothelial cell-dependent Notch activity in pericytes may be a key contributor to pericyte dysfunction or loss. Further studies are needed to determine the causal relationship between hyperglycemia, Notch signaling, and pericyte dropout.
